Arjo AB (FRA:A39) ROE % Adjusted to Book Value: 6.69% (As of Mar. 2026)


FRA:A39 Arjo AB FRA:A39
73 GF Score
Price €2.23
GF Value €3.27
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Arjo AB ROE % Adjusted to Book Value?

Arjo AB FRA:A39 +1.64% 73 ROE % Adjusted to Book Value is 6.69% as of Mar. 2026. GuruFocus rates FRA:A39 with a GF Score™ of 73/100 and a GF Value™ of €3.27 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Arjo AB's ROE % for the quarter that ended in Mar. 2026 was 5.69%. Arjo AB's PB Ratio for the quarter that ended in Mar. 2026 was 0.85. Arjo AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 6.69%.

Arjo AB ROE % Adjusted to Book Value Related Terms

Arjo AB ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Arjo AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arjo AB ROE % Adjusted to Book Value Chart

Arjo AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.66 4.32 4.43 5.46 3.72

Arjo AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.63 3.94 3.65 3.21 6.69

FRA:A39 vs MCK, CAH, COR: ROE % Adjusted to Book Value Comparison

For the Medical Distribution subindustry, Arjo AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arjo AB ROE % Adjusted to Book Value vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arjo AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Arjo AB's ROE % Adjusted to Book Value falls into.


FRA:A39
73GF Score
Arjo AB FRA:A39
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arjo AB ROE % Adjusted to Book Value Calculation

Arjo AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.35% / 1.17
=3.72%

Arjo AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.69% / 0.85
=6.69%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 6.69% mean?
Arjo AB (FRA:A39) has a ROE % Adjusted to Book Value of 6.69% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Arjo AB and its competitors.
Is Arjo AB's ROE % Adjusted to Book Value too high?
Arjo AB's current ROE % Adjusted to Book Value is 6.69%. Overall, Arjo AB has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's ROE % Adjusted to Book Value compare to MCK and CAH?
Arjo AB's ROE % Adjusted to Book Value of 6.69% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Distribution company?
A good ROE % Adjusted to Book Value depends on the Medical Distribution industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Arjo AB and its competitors. Arjo AB's current ROE % Adjusted to Book Value is 6.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (FRA:A39) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.27, compared to a current price of €2.23 — trading 31.8% below its estimated fair value. The current ROE % Adjusted to Book Value is 6.69%. Arjo AB's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Arjo AB (FRA:A39), the current ROE % Adjusted to Book Value is 6.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arjo AB (FRA:A39) Overvalued in 2026?

Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued. The current stock price of €2.23 is trading 31.8% below its estimated GF Value™ of €3.27. GuruFocus considers Arjo AB to be Significantly Undervalued.

Key valuation signals for FRA:A39:

  • ROE % Adjusted to Book Value: 6.69%
  • GF Value™: €3.27 vs. price of €2.23 (31.8% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the FRA:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arjo AB Business Description

Address Hans Michelsensgatan 10, Box 48, Malmo, SWE, SE-201 20
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
73GF Score

Get the complete analysis for FRA:A39

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.23
Price
€3.27
GF Value